ATE298578T1 - Lipid a-analoge enthaltende injektionen und verfahren zu deren herstellung - Google Patents

Lipid a-analoge enthaltende injektionen und verfahren zu deren herstellung

Info

Publication number: ATE298578T1
Authority: AT; Austria
Prior art keywords: analogues; production; containing lipid; injections containing; lipid
Prior art date: 1996-07-03

Application number

AT97929518T

Other languages

English (en)

Inventor

Yasuyuki Asai

Katsumi Onai

Kazuhide Ashizawa

Kiyoshi Iwamoto

Yasuo Ishibashi

Sumio Watanabe

Original Assignee

Eisai Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-07-03

Filing date

1997-07-03

Publication date

2005-07-15

1997-07-03 Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd

2005-07-15 Application granted granted Critical

2005-07-15 Publication of ATE298578T1 publication Critical patent/ATE298578T1/de

Links

239000007924 injection Substances 0.000 title abstract 3
238000004519 manufacturing process Methods 0.000 title abstract 3
150000002632 lipids Chemical class 0.000 title 1
238000002347 injection Methods 0.000 abstract 2
GZQKNULLWNGMCW-PWQABINMSA-N lipid A (E. coli) Chemical class O1[C@H](CO)[C@@H](OP(O)(O)=O)[C@H](OC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)[C@@H](NC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCC)[C@@H]1OC[C@@H]1[C@@H](O)[C@H](OC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](NC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](OP(O)(O)=O)O1 GZQKNULLWNGMCW-PWQABINMSA-N 0.000 abstract 2
239000007864 aqueous solution Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7024—Esters of saccharides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Dermatology (AREA)
Inorganic Chemistry (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT97929518T 1996-07-03 1997-07-03 Lipid a-analoge enthaltende injektionen und verfahren zu deren herstellung ATE298578T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP17361596		1996-07-03
PCT/JP1997/002316 WO1998001139A1 (fr)	1996-07-03	1997-07-03	Produits pour injection contenant des analogues de lipides a et procede de preparation correspondant

Publications (1)

Publication Number	Publication Date
ATE298578T1 true ATE298578T1 (de)	2005-07-15

Family

ID=15963903

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT97929518T ATE298578T1 (de)	1996-07-03	1997-07-03	Lipid a-analoge enthaltende injektionen und verfahren zu deren herstellung

Country Status (9)

Country	Link
US (1)	US6235724B1 (de)
EP (1)	EP0909562B1 (de)
CN (1)	CN1150001C (de)
AT (1)	ATE298578T1 (de)
CA (1)	CA2259520C (de)
DE (1)	DE69733651T2 (de)
DK (1)	DK0909562T3 (de)
ES (1)	ES2242226T3 (de)
WO (1)	WO1998001139A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU7799198A (en) *	1997-05-23	1998-12-21	Eisai Co. Ltd.	Method for preparing pharmaceutical formulation
EP1096954B1 (de) *	1998-07-14	2004-10-06	Wyeth Holdings Corporation	Monophosphoryllipid a enthaltende adjuvans- und impfstoffzusammensetzungen
US6306404B1 (en)	1998-07-14	2001-10-23	American Cyanamid Company	Adjuvant and vaccine compositions containing monophosphoryl lipid A
US6635261B2 (en)	1999-07-13	2003-10-21	Wyeth Holdings Corporation	Adjuvant and vaccine compositions containing monophosphoryl lipid A
EP2452684B1 (de)	2000-02-18	2018-01-24	Eisai R&D Management Co., Ltd.	Mizellen
SI2266603T1 (sl)	2000-10-18	2012-12-31	Glaxosmithkline Biologicals S.A.	Tumorska cepiva
WO2002094019A1 (en) *	2001-05-22	2002-11-28	Eisai Co., Ltd	Highly purified antiendotoxin compound
PL2068918T5 (pl)	2006-09-26	2024-12-02	Access To Advanced Health Institute	Kompozycja szczepionki zawierająca syntetyczny adiuwant
US20090181078A1 (en)	2006-09-26	2009-07-16	Infectious Disease Research Institute	Vaccine composition containing synthetic adjuvant
CA2735724C (en)	2008-06-19	2018-07-24	Variation Biotechnologies Inc.	Compositions and methods for treating influenza
CA2764374C (en)	2009-06-05	2019-11-19	Infectious Disease Research Institute	Synthetic glucopyranosyl lipid adjuvants
CA2803282C (en)	2009-07-06	2018-05-01	David E. Anderson	Methods for preparing vesicles and formulations produced therefrom
JP5854559B2 (ja)	2009-07-06	2016-02-09	ヴァリエーションバイオテクノロジーズインコーポレイテッド	小胞を調製する方法及びこれから製造される製剤
WO2012006367A2 (en)	2010-07-06	2012-01-12	Variation Biotechnologies, Inc.	Compositions and methods for treating influenza
BR112013018074A2 (pt)	2011-01-13	2020-12-01	Variation Biotechnologies, Inc.	métodos para a preparação de vesículas e formulações produzidas a partir dessas
US10736844B2 (en)	2011-01-13	2020-08-11	Variation Biotechnologies Inc.	Compositions and methods for treating viral infections
EA027236B1 (ru)	2011-04-08	2017-07-31	Иммьюн Дизайн Корп.	Иммуногенные композиции и способы применения таких композиций для индукции гуморального и клеточного иммунного ответа
AU2013208693B2 (en)	2012-01-12	2017-12-07	Variation Biotechnologies Inc.	Compositions and methods for treating viral infections
EP2806894A4 (de)	2012-01-27	2015-11-04	Variation Biotechnologies Inc	Verfahren und zusammensetzungen für therapeutika
HRP20181102T1 (hr)	2012-05-16	2018-09-07	Immune Design Corp	Cjepiva za hsv-2
MX370573B (es)	2013-04-18	2019-12-17	Immune Design Corp	Monoterapia con glucopiranosil lipido a para usarse en el tratamiento del cancer.
US9463198B2 (en)	2013-06-04	2016-10-11	Infectious Disease Research Institute	Compositions and methods for reducing or preventing metastasis
EP3242883A4 (de)	2015-01-06	2018-10-17	ImmunoVaccine Technologies Inc.	Lipid-a-mimetika, verfahren zur herstellung und verwendungen davon
WO2019051149A1 (en)	2017-09-08	2019-03-14	Infectious Disease Research Institute	LIPOSOMAL FORMULATIONS COMPRISING SAPONIN AND METHODS OF USE

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1216686B (it)	1988-04-01	1990-03-08	Chiesi Farma Spa	Formulazioni farmaceutiche acquose di piroxicam e procedimento per laloro preparazione.
JPH04198192A (ja) *	1990-11-28	1992-07-17	Japan Tobacco Inc	リピッドａ類縁体の水溶液
AU660325B2 (en) *	1991-10-11	1995-06-22	Eisai Co. Ltd.	Anti-endotoxin compounds and related molecules and methods
US5530113A (en) *	1991-10-11	1996-06-25	Eisai Co., Ltd.	Anti-endotoxin compounds
US5681824A (en) *	1995-06-05	1997-10-28	Eisai Co., Ltd.	Substituted liposaccharides useful in the treatment and prevention of endotoxemia

1997
- 1997-07-03 AT AT97929518T patent/ATE298578T1/de active
- 1997-07-03 EP EP97929518A patent/EP0909562B1/de not_active Expired - Lifetime
- 1997-07-03 DE DE69733651T patent/DE69733651T2/de not_active Expired - Lifetime
- 1997-07-03 DK DK97929518T patent/DK0909562T3/da active
- 1997-07-03 WO PCT/JP1997/002316 patent/WO1998001139A1/ja not_active Ceased
- 1997-07-03 ES ES97929518T patent/ES2242226T3/es not_active Expired - Lifetime
- 1997-07-03 US US09/194,704 patent/US6235724B1/en not_active Expired - Fee Related
- 1997-07-03 CA CA002259520A patent/CA2259520C/en not_active Expired - Fee Related
- 1997-07-03 CN CNB971960518A patent/CN1150001C/zh not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CA2259520A1 (en)	1998-01-15
DE69733651D1 (de)	2005-08-04
EP0909562B1 (de)	2005-06-29
CN1224355A (zh)	1999-07-28
ES2242226T3 (es)	2005-11-01
EP0909562A1 (de)	1999-04-21
WO1998001139A1 (fr)	1998-01-15
CN1150001C (zh)	2004-05-19
DK0909562T3 (da)	2005-08-22
DE69733651T2 (de)	2006-05-18
EP0909562A4 (de)	1999-12-29
US6235724B1 (en)	2001-05-22
CA2259520C (en)	2007-09-11

Legal Events

Date

Code

Title

Description

2006-01-15

UEP

Publication of translation of european patent specification

Ref document number: 0909562

Country of ref document: EP

2008-07-15

EEIH

Change in the person of patent owner

Publication	Publication Date	Title
ATE298578T1 (de)	2005-07-15	Lipid a-analoge enthaltende injektionen und verfahren zu deren herstellung
DE68904986D1 (de)	1993-04-01	Verfahren zur herstellung von 1,1,1-trifluor-2,2-dichlorethan.
DE68923805D1 (de)	1995-09-14	Verfahren zur herstellung von optisch aktivem 1,3-butanediol.
DE69006290D1 (de)	1994-03-10	N-Substituierte Benzyloxyiminderivate, Verfahren zu deren Herstellung und deren Verwendung.
DE60029589D1 (de)	2006-09-07	Verfahren zur herstellung von azithromycin
DE3785163D1 (de)	1993-05-06	3-pyrrolidinylthio-1-azabicyclo(3.2.0)hept-2-en-2-carbonsaeurederivate und verfahren zu deren herstellung.
ATE293595T1 (de)	2005-05-15	Thyroidhormon-analoga und verfahren zu ihrer herstellung
DE3772590D1 (de)	1991-10-10	Verfahren zur herstellung von 1,4-dihydropyridin-derivaten.
DE59001106D1 (de)	1993-05-06	Verfahren zur herstellung von 1,1,1-trifluor-2-chlorethan.
DE68912809D1 (de)	1994-03-17	Verfahren zur Herstellung von Bis(2,2,6,6-tetramethyl-4-piperidyl)amin.
DE68906500D1 (de)	1993-06-17	Verfahren zur herstellung von 2,6-dimethylnaphthalin.
DE3870065D1 (de)	1992-05-21	Zusammensetzungen von polyarylalkanoligomeren, verfahren zu deren herstellung.
DE68906372D1 (de)	1993-06-09	Verfahren zur herstellung von optisch aktiven threo-dihydroxyphenylserine-derivaten.
DE3869633D1 (de)	1992-05-07	Verfahren zur herstellung von n,n-(dibenzohexatrienylen)harnstoffen.
DE58904175D1 (de)	1993-06-03	Verfahren zur herstellung von 4,4'-dihalogeno-biphenylen.
DE69130215D1 (de)	1998-10-22	Verfahren zur herstellung von hexahydropyridazin-1,2-dicarbonsäurederivaten
DE59000677D1 (de)	1993-02-11	Verfahren zur herstellung von 2-cyan-3,3-diarylacrylsaeureestern.
ATE128113T1 (de)	1995-10-15	Calicheamicinon, dessen abkömmlinge und analogen und verfahren zu deren herstellung.
DE58906758D1 (de)	1994-03-03	Verfahren zur Herstellung eines faseroptischen Sternkopplers und nach diesem Verfahren hergestellter faseroptischer Sternkoppler.
DE68907180D1 (de)	1993-07-22	Verfahren zur herstellung von 2,3,5-trimethylbenzochinon.
DE68901576D1 (de)	1992-06-25	Verfahren zur herstellung von 2,3,5-trimethylbenzochinon.
DE69009329D1 (de)	1994-07-07	Leuchtemittierende Vorrichtung und Verfahren zu deren Herstellung.
DE3861897D1 (de)	1991-04-11	Verfahren zur herstellung von 4-hydroxy-2,2,6,6-tetramethyl-piperidin.
DE59005479D1 (de)	1994-05-26	Verfahren zur herstellung von chinophthalonderivaten.
DE58902813D1 (de)	1993-01-07	Verfahren zur herstellung von 4,4-dimethyl-l-(p-chlorphenyl)-pentan-3-on.